Horvath Steve, Lacunza Ezequiel, Mallat Martina Canatelli, Portiansky Enrique L, Gallardo Maria D, Brooke Robert T, Chiavellini Priscila, Pasquini Diana C, Girard Mauricio, Lehmann Marianne, Yan Qi, Lu Ake T, Haghani Amin, Gordevicius Juozas, Abba Martin, Goya Rodolfo G
Altos Labs, San Diego, USA.
Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Geroscience. 2025 Feb;47(1):809-823. doi: 10.1007/s11357-024-01269-y. Epub 2024 Jul 22.
Several studies have indicated that interrupted epigenetic reprogramming using Yamanaka transcription factors (OSKM) can rejuvenate cells from old laboratory animals and humans. However, the potential of OSKM-induced rejuvenation in brain tissue has been less explored. Here, we aimed to restore cognitive performance in 25.3-month-old female Sprague-Dawley rats using OSKM gene therapy for 39 days. Their progress was then compared with the cognitive performance of untreated 3.5-month-old rats as well as old control rats treated with a placebo adenovector. The Barnes maze test, used to assess cognitive performance, demonstrated enhanced cognitive abilities in old rats treated with OSKM compared to old control animals. In the treated old rats, there was a noticeable trend towards improved spatial memory relative to the old controls. Further, OSKM gene expression did not lead to any pathological alterations within the 39 days. Analysis of DNA methylation following OSKM treatment yielded three insights. First, epigenetic clocks for rats suggested a marginally significant epigenetic rejuvenation. Second, chromatin state analysis revealed that OSKM treatment rejuvenated the methylome of the hippocampus. Third, an epigenome-wide association analysis indicated that OSKM expression in the hippocampus of old rats partially reversed the age-related increase in methylation. In summary, the administration of Yamanaka genes via viral vectors rejuvenates the functional capabilities and the epigenetic landscape of the rat hippocampus.
多项研究表明,使用山中转录因子(OSKM)中断表观遗传重编程可以使来自老年实验动物和人类的细胞恢复活力。然而,OSKM诱导的脑组织年轻化的潜力尚未得到充分探索。在这里,我们旨在通过OSKM基因治疗39天来恢复25.3月龄雌性Sprague-Dawley大鼠的认知能力。然后将它们的进展与未治疗的3.5月龄大鼠以及用安慰剂腺病毒载体治疗的老年对照大鼠的认知能力进行比较。用于评估认知能力的巴恩斯迷宫测试表明,与老年对照动物相比,接受OSKM治疗的老年大鼠的认知能力有所增强。在接受治疗的老年大鼠中,相对于老年对照组,空间记忆有明显改善的趋势。此外,OSKM基因表达在39天内未导致任何病理改变。对OSKM治疗后的DNA甲基化分析得出了三点见解。第一,大鼠的表观遗传时钟显示出略微显著的表观遗传年轻化。第二,染色质状态分析表明,OSKM治疗使海马体的甲基化组恢复活力。第三,全表观基因组关联分析表明,老年大鼠海马体中OSKM的表达部分逆转了与年龄相关的甲基化增加。总之,通过病毒载体施用山中基因可使大鼠海马体的功能能力和表观遗传格局恢复活力。